In committee
Ensuring Lasting Smiles Act
Starting in 2026, commercial and employer-sponsored health insurance plans must cover inpatient and outpatient care for birth defects affecting the eyes, ears, teeth, mouth, or jaw. This mandate requires coverage for reconstructive procedures, follow-up care, and related dental or orthodontic treatment, regardless of standard dental exclusions. Insurers may not impose higher copays, deductibles, or coinsurance for these services than they do for standard medical and surgical benefits. Coverage does not extend to cosmetic surgeries performed on normal body structures for reasons unrelated to a diagnosed birth defect.
People affected—not determinable from the text provided; applies broadly to participants and beneficiaries in group and individual health plans diagnosed with qualifying congenital anomalies, but no specific population numbers are cited
Fiscal magnitude—no CBO estimate published
Reach55provisional · pending reviewrigor: heuristic llm
What this bill touches.
Market protections+30Government role in coverage+30
Who it helps · who it burdens.
Who it helps
- Individuals with craniofacial and related congenital anomalies or birth defectsGain guaranteed health insurance coverage for inpatient and outpatient diagnosis and treatment (including reconstructive surgery and adjunctive dental, orthodontic, and prosthodontic care) of congenital anomalies affecting the eyes, ears, teeth, mouth, or jaw, subject to standard cost-sharing limits (Sec. 2(a)–(c)).
Who it burdens
- Group health plans and health insurance issuersAre mandated to cover medically necessary reconstructive, dental, orthodontic, and prosthodontic services for congenital anomalies regardless of standard dental exclusions, limit cost-sharing to general medical benefit levels, and issue coverage notices to enrollees by January 1, 2026 (Sec. 2(a)–(c), (e)).
- Department of Health and Human ServicesMust conduct a study and submit a report to Congress by December 31, 2027, evaluating provider network adequacy, changes in out-of-pocket costs, and overall procedure costs for covered congenital anomaly services (Sec. 2(d)).